These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19736010)

  • 1. Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations.
    Collins J; Bove KE; Dimmock D; Morehart P; Wong LJ; Wong B
    Neuromuscul Disord; 2009 Nov; 19(11):784-7. PubMed ID: 19736010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
    Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
    Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
    Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
    Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversion of mtDNA depletion in a patient with TK2 deficiency.
    Vilà MR; Segovia-Silvestre T; Gámez J; Marina A; Naini AB; Meseguer A; Lombès A; Bonilla E; DiMauro S; Hirano M; Andreu AL
    Neurology; 2003 Apr; 60(7):1203-5. PubMed ID: 12682338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal mitochondrial myopathy and mitochondrial DNA depletion.
    Tulinius M; Moslemi AR; Darin N; Holme E; Oldfors A
    Neuromuscul Disord; 2005 Jun; 15(6):412-5. PubMed ID: 15907288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion.
    Leshinsky-Silver E; Michelson M; Cohen S; Ginsberg M; Sadeh M; Barash V; Lerman-Sagie T; Lev D
    Eur J Paediatr Neurol; 2008 Jul; 12(4):309-13. PubMed ID: 17951082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset thymidine kinase 2 deficiency: a review of 18 cases.
    Domínguez-González C; Hernández-Laín A; Rivas E; Hernández-Voth A; Sayas Catalán J; Fernández-Torrón R; Fuiza-Luces C; García García J; Morís G; Olivé M; Miralles F; Díaz-Manera J; Caballero C; Méndez-Ferrer B; Martí R; García Arumi E; Badosa MC; Esteban J; Jimenez-Mallebrera C; Encinar AB; Arenas J; Hirano M; Martin MÁ; Paradas C
    Orphanet J Rare Dis; 2019 May; 14(1):100. PubMed ID: 31060578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene.
    Martí R; Nascimento A; Colomer J; Lara MC; López-Gallardo E; Ruiz-Pesini E; Montoya J; Andreu AL; Briones P; Pineda M
    Pediatr Res; 2010 Aug; 68(2):151-4. PubMed ID: 20421844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
    Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
    Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations.
    Roos S; Lindgren U; Ehrstedt C; Moslemi AR; Oldfors A
    Neuromuscul Disord; 2014 Aug; 24(8):713-20. PubMed ID: 24953930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency.
    Vilà MR; Villarroya J; García-Arumí E; Castellote A; Meseguer A; Hirano M; Roig M
    J Neurol Sci; 2008 Apr; 267(1-2):137-41. PubMed ID: 18021809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
    Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
    Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.
    Blakely E; He L; Gardner JL; Hudson G; Walter J; Hughes I; Turnbull DM; Taylor RW
    Neuromuscul Disord; 2008 Jul; 18(7):557-60. PubMed ID: 18508266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular features of mitochondrial DNA depletion syndromes.
    Spinazzola A; Invernizzi F; Carrara F; Lamantea E; Donati A; Dirocco M; Giordano I; Meznaric-Petrusa M; Baruffini E; Ferrero I; Zeviani M
    J Inherit Metab Dis; 2009 Apr; 32(2):143-58. PubMed ID: 19125351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion.
    Zhang S; Li FY; Bass HN; Pursley A; Schmitt ES; Brown BL; Brundage EK; Mardach R; Wong LJ
    Mol Genet Metab; 2010 Jan; 99(1):53-7. PubMed ID: 19815440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion.
    Nevo Y; Soffer D; Kutai M; Zelnik N; Saada A; Jossiphov J; Messer G; Shaag A; Shahar E; Harel S; Elpeleg O
    J Child Neurol; 2002 Jul; 17(7):499-504. PubMed ID: 12269728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.
    Béhin A; Jardel C; Claeys KG; Fagart J; Louha M; Romero NB; Laforêt P; Eymard B; Lombès A
    Neurology; 2012 Feb; 78(9):644-8. PubMed ID: 22345218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
    Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
    BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA.
    Mancuso M; Salviati L; Sacconi S; Otaegui D; Camaño P; Marina A; Bacman S; Moraes CT; Carlo JR; Garcia M; Garcia-Alvarez M; Monzon L; Naini AB; Hirano M; Bonilla E; Taratuto AL; DiMauro S; Vu TH
    Neurology; 2002 Oct; 59(8):1197-202. PubMed ID: 12391347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.
    Saada A; Shaag A; Mandel H; Nevo Y; Eriksson S; Elpeleg O
    Nat Genet; 2001 Nov; 29(3):342-4. PubMed ID: 11687801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.